Skip to main content
Log in

Carcinoembryonic antigen: Function in metastasis by human colorectal carcinoma

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Carcinoembryonic antigen (CEA) is a glycoprotein that has been useful as a tumor marker to predict recurrence in gastrointestinal malignancies, but whose biological function has not been elucidated. With the recent evidence that CEA is a member of the immunoglobulin supergene family, CEA may be involved in intercellular recognition and binding. This review examines the role that CEA plays in the development of mestastases by colorectal carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gold P, Freedman SO: Demonstration of tumor-specific antigens inhuman colonic carcinoma by immunological tolerance and absorption techniques. J Exp Med 121: 439–462, 1965

    Google Scholar 

  2. Shively JE, Todd CW: Carcinoembryonic antigen: chemistry and biology. In: Sell S (ed) Cancer Markers: Developmental and Diagnostic Significance. Clifton, NJ, Humana Press, 1980, pp 295–314

    Google Scholar 

  3. Plow EF, Edgington TS: Speciation of carcinoembryonic antigen and its immunodiagnostic implications. In: Herberman RB, McIntire KR (eds) Immunodiagnosis of Cancer, Marcel Dekker, Inc. New York, 1979

    Google Scholar 

  4. Shively JE, Beatty JD: CEA-related antigens: Molecular biology and clinical significance. CRC Crit Rev Onc Hemat 2: 355–399, 1985

    Google Scholar 

  5. Thompson J, Zimmerman W: The carcinoembryonic antigen gene family: Structure, expression and evolution. Tumor Biol 9: 63–83, 1988

    Google Scholar 

  6. Chandrasekaran EV, Davila M, Nixon DW, Goldfarb M, Mendicino J: Isolation and structures of the oligosaccharide units of carcinoembryonic antigen. J Biol Chem 258: 7213–7222, 1983

    Google Scholar 

  7. Rogers GT: Carcinoembryonic antigens and related glycoproteins. Molecular aspects and specificity. Biochim Biophys Acta 695: 227–249, 1983

    Google Scholar 

  8. Oikawa S, Nakazato H, Kosaki G: Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequence. Biochem Biophys Res Commun 142: 511–518, 1987

    Google Scholar 

  9. Sack T, Gum J, Low M, Kim Y: Release of carcinoembryonic antigen from human colon cancer cells by phosphoinositol-specific phospholipase C. J Clin Invest 82: 586–593, 1988

    Google Scholar 

  10. Hefta S, Hefta L, Lee T, Paxton R, Shively J: Carcinoembryonic antigen is anchored to membranes by covalent attachment to a glycosylphosphatidylinositol moiety: Identification of the ethanolamine linkage site. Proc Natl Acad Sci USA 85: 4648–4652, 1988

    Google Scholar 

  11. Barnett TR, Kretschmer A, Austen DA, Goebel SJ, Hart JT, Elting JJ, Kamarck ME: Carcinoembryonic antigens: alternative splicing accounts for the multiple mRNAs that code for the novel members of the carcinoembryonic antigen family. J Cell Biol 108: 267–276, 1989

    Google Scholar 

  12. Thompson JA, Mauch EM, Chen FS, Hinoda Y, Schrewe H, Berling B, Barnert S, von Kleist S, Shively JE, Zimmermann W: Analysis of the size of the carcinoembryonic antigen (CEA) gene family: Isolation and sequencing of N-terminal domain exons. Biochem Biophys Res Commun 158: 996–1004, 1989

    Google Scholar 

  13. Tse AGD, Barkley AN, Watts A, Williamson AF: A glycophospholipid tail at the carboxy terminus of the Thy-1 glycoprotein of neurones and thymocytes. Science 230: 1003–1008, 1985

    Google Scholar 

  14. Cunningham B, Hemperly J, Murray B, Prediger E, Brackenbury R, Edelman B: Neural cell adhesion molecule: structure, lg-like domains, cell surface modulation and alternative RNA splicing. Science 236: 766–806, 1987

    Google Scholar 

  15. Mostov KE, Friedlander M, Blobel G: The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin like domains. Nature 308: 37–43, 1984

    Google Scholar 

  16. Ishioka N, Takahashi N, Putnam FW: Amino acid sequence of human plasma alphaI β-glycoprotein: Homology to the immunoglobulin supergene family. Proc Natl Acad Sci USA 83: 2363–2367, 1986

    Google Scholar 

  17. Hemperly JJ, Murray BA, Edelman GM, Cunningham BA: Sequence of a cDNA clone encoding the polysialic acid rich and cytoplasmic domains of the neural cell adhesion molecule N-CAM. Proc Natl Acad Sci USA 83: 3037–3041, 1986

    Google Scholar 

  18. Salzer J, Holmes W, Coleman D: The amino acid sequences of the myelin-associated glycoproteins: Homology to the immunoglobulin gene superfamily. J Cell Biol 104: 957–965, 1987

    Google Scholar 

  19. Williams AF, Barclay AN: The immunoglobulin superfamily-domains for cell surface recognition. Ann Rev Immunol 6: 381–405, 1988

    Google Scholar 

  20. Westwood JH, Thomas P, Edwards RG, Scopes PM, Barrett MW: Chemical modifications of the protein of carcinoembryonic antigen (CEA): Associated changes in immunological activity and conformation. Br J Cancer 37: 183–189, 1978

    Google Scholar 

  21. Oikawa S, Imajo S, Noguchi T, Kosaki G, Nakazato H: The carcinoembryonic antigen (CEA) contains multiple immunoglobulin like domains. Biochem Biophys Res Commun 144: 634–642, 1987

    Google Scholar 

  22. Thomson DMP, Krupey J, Freedman SO, Gold P: The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Natl Acad Sci USA 64: 161–167, 1969

    Google Scholar 

  23. Holyoke ED, Block GE, Elwood J, Sizemore GW, Heath H, Chu TM, Murphy GP, Mittelman A, Ruddon RW, Arnott MS: Biologic markers in cancer diagnosis and treatment. Curr Prob Cancer 6: 1–57, 1981

    Google Scholar 

  24. Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK, Oettgen HF: Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer N Engl J Med 299: 448–451, 1978

    Google Scholar 

  25. Goslin R, Steele GJr, Macintyre J, Mayer R, Sugarbaker P, Cleghorn K, Wilson R, Zamcheck N: The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancers. Ann Surg 192: 747–751, 1980

    Google Scholar 

  26. Steele GJr, Zamcheck N: The use of carcinoembryonic antigen in the clinical management of patients with colorectal cancer. Cancer Detect Prev 8: 421–427, 1985

    Google Scholar 

  27. Steele GJr, Ellenberg S, Ramming K, O'Connell M, Moertel C, Lessner H, Bruckner H, Horton J, Schein P, Zamcheck N, Novak J, Holyoke ED: CEA monitoring among patients in multi-institutional adjuvant G. I. therapy protocols. Ann Surg 196: 162–169, 1982

    Google Scholar 

  28. Bartal AH, Ayalon D, Cordova T, Avidan SH, Robinson E: Carcinoembryonic antigen in patients with colorectal cancer: Correlation between stage of disease and antigen level. Isr J Med Sci 19: 801–805, 1983

    Google Scholar 

  29. Koch M, Washer G, Gaedke H, McPherson TA: Carcinoembryonic antigen: Usefulness as a post-surgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers. JNCl 69: 813–815, 1982

    Google Scholar 

  30. Kimura O, Kaibara N, Nishidoi H, Okamoto T, Takebayashi M, Kawasumi H, Koga S: Carcinoembryonic antigen slope analysis as an early indicator for recurrence of colorectal carcinoma. Jpn J Surg 16: 106–111, 1986

    Google Scholar 

  31. Fucini C, Tommasi MS, Cardona G, Malatantis G, Panichi S, Bettini U: Limitations of CEA monitoring as a guide to second-look surgery in colorectal cancer followup. Tumori 69: 359–364, 1983

    Google Scholar 

  32. Denstman F, Rosen L, Khubchandani IT, Sheets JA, Stasnik JJ, Riether RD: Comparing predictive decision rules in postoperative CEA monitoring. Cancer 58: 2089–2095, 1986

    Google Scholar 

  33. Wiggers T, Arends JW, Verstijnen C, Moerkerk PM, Bosman FT: Prognostic significance of CEA immunoreactivity patterns in large bowel carcinoma tissue. Br J Cancer 54: 409–414, 1986

    Google Scholar 

  34. Huitric E, Laumonier R, Burtin P, von Kleist S, Chavenal G: An optical and ultrastructural study of the localization of carcinoembryonic antigen (CEA) in normal and cancerous human rectocolonic mucosa. Lab Invest 34: 97–105, 1976

    Google Scholar 

  35. Ahnen DJ, Nakane PK, Brown WR: Ultrastructural localization of carcinoembryonic antigen in normal intestine and colon cancer: abnormal distribution of CEA on the surfaces of colon cancer cells. Cancer 49: 2077–2090, 1982

    Google Scholar 

  36. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP: Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57: 327–334, 1989

    Google Scholar 

  37. Nap M, Mollgard K, Burtin P, Fleuren GJ: Immunohistochemistry of carcino-embryonic antigen in the embryo, fetus and adult. Tumor Biol 9: 145–153, 1988

    Google Scholar 

  38. Cosimelli M, De Peppo F, Castelli M, Giannarelli D, Schinaia G, Castaldo P, Buttini GL, Sciarretta F, Bigotti G, Di Filippo F, Cavaliere F, Cavaliere R: Multivariate analysis of a tissue CEA, TPA, and CA 19.9 quantitative study in colorectal cancer patients: A preliminary finding. Dis Colon Rectum 32: 389–397, 1989

    Google Scholar 

  39. Shi ZR, Tsao D, Kim YS: Subcellular distribution, synthesis, and release of carcinoembryonic antigen in cultured human colon adenocarcinoma cell lines. Cancer Res 43: 4045–4049, 1983

    Google Scholar 

  40. Laurence DJR, Neville AM: The detection and evaluation of human tumor metastases. Cancer Metast Rev 2: 351–374, 1983

    Google Scholar 

  41. Bates SE, Longo DL: Tumor markers: value and limitations in the management of cancer patients. Cancer Treat Rev 12: 163–207, 1985

    Google Scholar 

  42. Thomas P, Hems DA: The hepatic clearance of circulating native and asialo carcinoembryonic antigen by the rat. Biochem Biophys Res Commun 67: 1205–1209, 1975

    Google Scholar 

  43. Toth CA, Rapoza A, Zamcheck N, Steele G, Thomas P: Receptor-mediated endocytosis of carcinoembryonic antigen by rat alveolar macrophages in vitro. J Leuk Biol 45: 370–376, 1989

    Google Scholar 

  44. Willson JKV, Bittner GN, Oberley TD, Meisner LF, Weese JL: Cell culture of human colon adenomas and carcinomas. Cancer Res 47: 2704–2713, 1987

    Google Scholar 

  45. Rygaard J, Povlsen CO: Heterotransplantation of a human malignant tumour to ‘Nude’ mice. Acta Pathol Microbiol Scand 77: 758–760, 1969

    Google Scholar 

  46. Povlsen CO, Rygaard J: In: Bloom BR, David JR (eds) In Vitro Methods of Cell-Mediated and Tumor Immunity. New York. Academic Press, 1976, p. 701

    Google Scholar 

  47. Fogh J, Bean MA, Bruggen J, Fogh H, Hammar SP, Kodera Y, Loveless ID, Sorg C, Wright W. In: Fogh J, Giovanella BC (eds) The Nude Mouse in Experimental and Clinical Research. Academic Press, New York, 1978, p. 215

    Google Scholar 

  48. Povlsen C, Rygaard J, Fogh J. In: Fogh J, Giovanella BC (eds) The Nude Mouse in Experimental and Clinical Research. Academic Press. New York, 1982, p. 79

    Google Scholar 

  49. Sharkey FE, Fogh J: Considerations in the use of nude mice for cancer research. Cancer Metastasis Rev 3: 341–360, 1984

    Google Scholar 

  50. Giovanella BC, Stehlin JS, Williams LJJr: Heterotrans-plantation of human malignant tumors in ‘nude’ thymusless mice. II. Malignant tumors induced by injection of cell cultures derived from human solid tumors. J Natl Cancer Inst 52: 921–930, 1974

    Google Scholar 

  51. Outzen HC, Custer RP: Growth of human normal and neoplastic mammary tissues in the cleared mammary fat pad of the nude mouse. J Natl Cancer Inst 55: 1461–1466, 1975

    Google Scholar 

  52. Reid LC, Shin SI. In: Fogh J, Giovanella BC (eds) The Nude Mouse in Experimental and Clinical Research. Academic Press, New York, 1978, p. 313

    Google Scholar 

  53. Giovanella BC, Stehlin JS, Shepard RC, Williams LJ: Correlation between response to chemotherapy of human tumors in patients and in nude mice. Cancer 52: 1146–1152, 1983

    Google Scholar 

  54. Fogh J, Orfeo T, Tiso J, Sharkey FE: Establishment of human colon carcinomas in nude mice. Exp Cell Biol 47: 136–144 1979

    Google Scholar 

  55. Martin KW, Halpern SE: Carcinoembryonic antigen production, secretion, and kinetics in BALB/c mice and a nude mouse-human tumor model. Cancer Research 44: 5475–5481, 1984

    Google Scholar 

  56. Walton J, Winterbourne D, Fiennes A, Harris P, Hermon-Taylor J, Grant A: Human tumour cell lines established in vitro from tumours after long-term passage as nude mouse xenografts. Comparative fingerprinting of their concanavalin-A acceptor glycoproteins. Br J Cancer 51: 675–680, 1985

    Google Scholar 

  57. Pratesi G, Pezzoni G, Giardini R, Doci R, Valente M, Parmiani G: Growth characteristics of human colorectal and non-small cell lung tumors xenografted into nude mice: possible correlation with prognosis. Tumori 72: 351–356, 1986

    Google Scholar 

  58. Friedlander ML, Russell P, Taylor IW, Tattersall MHN: Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer. Br J Cancer 51: 319–333, 1985

    Google Scholar 

  59. Rousseau-Merck MF, Bigel P, Mouly H, Flamant F, Zucker JM, Wache AC, Nezelof C: Transplantability in nude mice of embryonic and other childhood tumours. Br J Cancer 51: 279–283, 1985

    Google Scholar 

  60. Mattern J, Jager S, Sonka J, Wayss K, Volm M: Growth of human bronchial carcinomas in nude mice. Br J Cancer 51: 195–200, 1985

    Google Scholar 

  61. Kleine W: Prognostic significance of growth characteristics of xenotransplanted ovarian carcinomas into nude mice. Gynecol Oncol 25: 65–72, 1986

    Google Scholar 

  62. Kozlowski JM, Fidler IJ, Campbell D, Xu Z-L, Kaighn ME, Hart IR: Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 44: 3522–3529, 1984

    Google Scholar 

  63. Giayazzi R, Campbell DE, Jessup JM, Cleary K, Fidler IJ: Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res 46: 1928–1933, 1986

    Google Scholar 

  64. Giavazzi R, Jessup JM, Campbell DE, Walker SM, Fidler IJ: Experimental nude mouse model of human colorectal cancer liver metastases. J Natl Cancer Inst 77: 1303–1308, 1986

    Google Scholar 

  65. Morikawa K, Walker SM, Jessup JM, Fidler IJ: In vivo selection of highly metastatic cells from surgical specimens of different human colon carcinomas implanted into nude mice. Cancer Res 48: 1943–1948, 1988

    Google Scholar 

  66. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ: Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 48: 6863–6871, 1988

    Google Scholar 

  67. Thomas P, Birbeck MWC, Cartwright P: A radioautographic study of the hepatic uptake of circulating carcinoembryonic antigen by the mouse. Biochem Soc Trans 5: 312–313, 1977

    Google Scholar 

  68. Niles RM, Wilhelm SA, Steele GD, Burke B, Christensen T, Dexter D, O'Brien MJ, Thomas P, Zamcheck N: Isolation and characterization of an undifferentiated human colon cancer cell line (MIP-101). Cancer Invest 5: 545–552, 1987

    Google Scholar 

  69. Poste G, Fidler IJ: The pathogenesis of cancer metastasis. Nature (London) 283: 139–146, 1979

    Google Scholar 

  70. Fidler IJ: Selection of successive tumour lines for metastasis. Nature New Biol 242: 148–149, 1973

    Google Scholar 

  71. Nicolson GL: Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Met Rev 7: 143–188, 1988

    Google Scholar 

  72. Fidler IJ, Hart IR: Biological diversity in metastatic neoplasms: Origins and implications. Science 217: 998–1003, 1982

    Google Scholar 

  73. Fidler IJ, Kripke ML: Metastasis results from preexisting variant cells within a malignant tumor. Science 197: 893–895, 1977

    Google Scholar 

  74. Gabbert H: Mechanisms of tumor invasion: evidence from in vivo observations. Cancer Metastasis Rev 4: 293–309, 1985

    Google Scholar 

  75. Boyd D, Florent G, Childress-Fields K, Brattain MG: Alteration in the behavior of a colon carcinoma cell line by extracellular matrix components. Cancer Lett 41: 81–90, 1988

    Google Scholar 

  76. Boyd D, Ziober B, Chakrabarty S, Brattain MG: Examination of urokinase protein/transcript levels and their relationship with laminin degradation in cultured colon carcinoma. Cancer Res 49: 816–820, 1989

    Google Scholar 

  77. Daneker GWJr, Mercurio AM, Guerra L, Wolf B, Salem RR, Bagli DJ, Steele GDJr: Laminin expression in colorectal carcinomas varying in degree of differentiation Arch Surg 122: 1470–1474, 1987

    Google Scholar 

  78. Chakrabarty S, Tobon A, Varani J, Brattain MG: Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor beta. Cancer Res 48: 4059–4064, 1988

    Google Scholar 

  79. Primus FJ, Clark CA, Goldenberg DM: Immunoperoxidase localization of carcinoembryonic antigen in normal human intestinal mucosa. J Natl Cancer Inst 67: 1031–1039, 1981

    Google Scholar 

  80. O'Brien MJ, Zamcheck N, Burke B, Kirkham SE, Saravis CA, Gottlieb LS: Immunocytochemical localization of carcinoembryonic antigen in benign and malignant colorectal tissues: assessment of diagnostic value. Am J Clin Pathol 75: 283–290, 1981

    Google Scholar 

  81. Nakane PK, Watanabe T: Distribution of oncodevelopmental markers in neoplastic cells: therapeutic implications. J Histochem Cytochem 32: 894–898, 1984

    Google Scholar 

  82. Lisowska E, Krop-Watorek A, Sedlaczek P: The dimeric structure of carcinoembryonic antigen (CEA). Biochem Biophys Res Comm 115: 206–211, 1983

    Google Scholar 

  83. Krop-Watorek A, Sedlaczek P, Lisowska E: The subunit structure of non-specific cross-reacting antigen (NCA). Mol-Immunol 20: 777–785, 1983

    Google Scholar 

  84. Toth CA, Thomas P, Rapoza A, Sherman M, Steele GD: Carcinoma orosomucoid related antigen (CORA), a carcinembryonic antigen binding protein isolated from malignant ascites. FASEB J 2:A851, 1988

    Google Scholar 

  85. Updike TV, Nicolson GL: Malignant melanoma cell lines selected in vitro for increased homotypic adhesion propertics have increased experimental metastatic potential. Clin Exp Met 4: 273–284, 1986

    Google Scholar 

  86. Lotan R, Raz A: Endogenous lectins as mediators of tumor cell adhesion (review). J Cell Biochem 37: 107–117, 1988

    Google Scholar 

  87. Gold P: Circulating antibodies against carcinoembryonic antigens of the human digestive system. Cancer 20: 1663–1667, 1967

    Google Scholar 

  88. MacSween JM: The antigenicity of carcinoembryonic antigen in man. Int J Cancer 15: 246–252, 1975

    Google Scholar 

  89. Collatz E, von Kleist S, Burtin P: Further investigation of circulating antibodies in colon cancer patients: on the autoantigenicity of the carcinoembryonic antigen. Int J Cancer 8: 298–303, 1971

    Google Scholar 

  90. Ura Y, Ochi Y, Hamazu M, Ishida M, Nakajima K, Watanabe T: Studies on circulating antibody against carcinoembryonic antigen (CEA) and CEA-like antigen in cancer patients. Cancer Lett 25: 283–295, 1985

    Google Scholar 

  91. Orefice S, Fossati G, Pietrojusti E, Bonfanti G: Delayed cutaneous hypersensitivity reaction to carcinoembryonic antigen in cancer patients. Tumori 68: 473–475, 1982

    Google Scholar 

  92. Hakim AA: Carcinoembryonic antigen, a tumor-associated glycoprotein induces defective lymphocyte function. Neoplasma 31: 385–397, 1984

    Google Scholar 

  93. Hostetter R, Augustus LB, Mankarious R, Chi K, Fan D, Thomas P, Jessup JM: Carcinoembryonic antigen as an attachment factor for metastasis. Arch Surg (submitted)

  94. Medoff JR, Jegasothy BV, Roche JK: Carcinoembryonic antigen-induced release of a suppressor factor from normal human lymphocytes in vitro. Cancer Res 44: 5822–5827, 1984

    Google Scholar 

  95. Khima I, Ezawa K, Toyoshima S, Furuhata K, Ogura H, Osawa T: Induction of suppressor T cells by neuraminic acid derivatives. Chem Pharm Bull 30: 3278–3283, 1982

    Google Scholar 

  96. Heiskala MK, Stenman UH, Koivunen E, Carpen O, Saksela E, Timonen T: Characteristics of soluble tumourderived proteins that inhibit natural killer activity. Scand J Immunol 28: 19–27, 1988

    Google Scholar 

  97. Clark DA, McCulloch PB, Liao S-K, Dent PB, Fuks A: Sensitivity of human carcinoma cell lines to lysis by blood natural killer cells correlating with surface expression of carcinoembryonic antigen. J Natl Cancer Inst 72: 505–512, 1984

    Google Scholar 

  98. Bagli DJ, Steele GD, Barlozzari T: Natural killer sensitivity of colorectal carcinoma targets: correlation with degree of differentiation. Arch Surg 124: 89–93, 1989

    Google Scholar 

  99. Niles RM, Wilhelm SA, Thomas P, Zamcheck N: The effect of sodium butyrate and retanoic acid on growth and CEA production in a series of human colorectal tumor cell lines representing different states of differentiation. Cancer Invest 6: 39–45, 1988

    Google Scholar 

  100. Wisse E, DeZanger RB, Jacobs R, McCuskey RS: Scanning electron microscope observations on the structure of portal veins, sinusoids and central veins in rat liver. Scan Electron Microsc (III): 1441–1452, 1983

  101. Macchiarelli G, Motta P: The three-dimensional microstructure of the liver. A review by scanning electron microscopy. Scan-Electron-Microsc (III): 1019–1038, 1986

  102. Martinez-Hernandez A: The hepatic extracellular matrix. I. Electronimmunohistochemical studies in normal rat liver. Lab Invest 51: 57–74, 1984

    Google Scholar 

  103. Byrn R, Medrek P, Thomas P, Jcanloz R, Zamcheck N: Effect of heterogeneity of CEA on liver cell membrane binding and its kinetics of removal from circulation. Cancer Res 45: 3137, 1985

    Google Scholar 

  104. McCarthy JB, Skubitz APN, Palm SL, Furcht LT: Metastasis inhibition of different tumor types by purified laminin fragments and a heparin-binding fragment of fibronectin. J Natl Cancer Inst 80: 108–116, 1988

    Google Scholar 

  105. Tabuchi Y, Deguchi H, Imanishi K, Saitoh Y: Comparison of carcinoembryonic antigen levels between portal and peripheral blood in patients with colorectal cancer: Correlation with histopathologic variables. Cancer 59: 1283–1288, 1987

    Google Scholar 

  106. Kodama T, Fugino M, Endo Y, Fukayama M, Sugiura M, Oda T, Wada T, Burlin P: Carcinoembryonic antigen (CEA) and CEA-like substances in hepatobiliary diseases. In: Lehmann F (ed) Carcinoembryonic proteins. Elsevier Biomedical Press, New York, 1979, vol. 2, pp 93–97

    Google Scholar 

  107. Toth CA, Thomas P, Broitman SA, Zamcheck N: A new Kupffer cell receptor mediating plasma clearance of carcinoembryonic antigen by the rat. Biochem J 204: 377–381, 1982

    Google Scholar 

  108. Toth CA, Thomas P, Broitman SA, Zamcheck N: Receptor-mediated endocytosis of carcinoembryonic antigen by rat liver Kupffer cells. Cancer Res 45: 392–397, 1985

    Google Scholar 

  109. Thomas P, Toth CA: Site of carcinoembryonic antigen binding to Kupffer cells. Biochem Soc Trans (in press).

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by grant RO1CA42587 from the U.S. Department of Health and Human Services.

Supported by grants RO1CA44586 and PO1CA44704 from the U.S. Department of Health and Human Services.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jessup, M., Thomas, P. Carcinoembryonic antigen: Function in metastasis by human colorectal carcinoma. Cancer Metast Rev 8, 263–280 (1989). https://doi.org/10.1007/BF00047341

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00047341

Key words

Navigation